Skip to main content
Top
Published in: Inflammation 6/2013

Open Access 01-12-2013

MHV68 Latency Modulates the Host Immune Response to Influenza A Virus

Authors: Fumitake Saito, Toshihiro Ito, Judith M. Connett, Matthew A. Schaller, William F. Carson IV, Cory M. Hogaboam, Rosemary Rochford, Steven L. Kunkel

Published in: Inflammation | Issue 6/2013

Login to get access

Abstract

Murine gammaherpesvirus 68 (MHV68) is a natural rodent pathogen that has been used as a model to study the pathogenesis of human gammaherpesviruses. Like other herpesviruses, MHV68 causes acute infection and establishes life-long latency in the host. Recently, it has been shown that mice latently infected with MHV68 have resistance to unrelated pathogens in secondary infection models. We therefore hypothesized that latent MHV68 infection could modulate the host response to influenza A virus. To test this hypothesis, mice were infected intranasally with influenza virus following the establishment of MHV68 latency. Mice latently infected with MHV68 showed significantly higher survival to influenza A virus infection than did PBS mock-infected mice. Latent MHV68 infection led to lower influenza viral loads and decreased inflammatory pathology in the lungs. Alveolar macrophages of mice latently infected with MHV68 showed activated status, and adoptive transfer of those activated macrophages into mice followed the infection with influenza A virus had significantly greater survival rates than control mice, suggesting that activated alveolar macrophages are a key mechanistic component in protection from secondary infections.
Literature
1.
go back to reference Selin, L.K., S.M. Varga, I.C. Wong, and R.M. Welsh. 1998. Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations. Journal of Experimental Medicine 188: 1705–1715.PubMedCrossRef Selin, L.K., S.M. Varga, I.C. Wong, and R.M. Welsh. 1998. Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations. Journal of Experimental Medicine 188: 1705–1715.PubMedCrossRef
2.
go back to reference Walzl, G., S. Tafuro, P. Moss, P.J. Openshaw, and T. Hussell. 2000. Influenza virus lung infection protects from respiratory syncytial virus-induced immunopathology. The Journal of Experimental Medicine 192: 1317–1326.PubMedCrossRef Walzl, G., S. Tafuro, P. Moss, P.J. Openshaw, and T. Hussell. 2000. Influenza virus lung infection protects from respiratory syncytial virus-induced immunopathology. The Journal of Experimental Medicine 192: 1317–1326.PubMedCrossRef
3.
go back to reference Welsh, R.M., J.W. Che, M.A. Brehm, and L.K. Selin. 2010. Heterologous immunity between viruses. Immunological Reviews 235: 244–266.PubMed Welsh, R.M., J.W. Che, M.A. Brehm, and L.K. Selin. 2010. Heterologous immunity between viruses. Immunological Reviews 235: 244–266.PubMed
4.
go back to reference Clute, S.C., L.B. Watkin, M. Cornberg, Y.N. Naumov, J.L. Sullivan, K. Luzuriaga, R.M. Welsh, and L.K. Selin. 2005. Cross-reactive influenza virus-specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosis. The Journal of Clinical Investigation 115: 3602–3612.PubMedCrossRef Clute, S.C., L.B. Watkin, M. Cornberg, Y.N. Naumov, J.L. Sullivan, K. Luzuriaga, R.M. Welsh, and L.K. Selin. 2005. Cross-reactive influenza virus-specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosis. The Journal of Clinical Investigation 115: 3602–3612.PubMedCrossRef
5.
go back to reference Mathurin, K.S., G.W. Martens, H. Kornfeld, and R.M. Welsh. 2009. CD4 T-cell-mediated heterologous immunity between mycobacteria and poxviruses. Journal of Virology 83: 3528–3539.PubMedCrossRef Mathurin, K.S., G.W. Martens, H. Kornfeld, and R.M. Welsh. 2009. CD4 T-cell-mediated heterologous immunity between mycobacteria and poxviruses. Journal of Virology 83: 3528–3539.PubMedCrossRef
6.
go back to reference Ackermann, M. 2006. Pathogenesis of gammaherpesvirus infections. Veterinary Microbiology 113: 211–222.PubMedCrossRef Ackermann, M. 2006. Pathogenesis of gammaherpesvirus infections. Veterinary Microbiology 113: 211–222.PubMedCrossRef
7.
go back to reference Olivadoti, M., L.A. Toth, J. Weinberg, and M.R. Opp. 2007. Murine gammaherpesvirus 68: A model for the study of Epstein-Barr virus infections and related diseases. Comparative Medicine 57: 44–50.PubMed Olivadoti, M., L.A. Toth, J. Weinberg, and M.R. Opp. 2007. Murine gammaherpesvirus 68: A model for the study of Epstein-Barr virus infections and related diseases. Comparative Medicine 57: 44–50.PubMed
8.
go back to reference McClellan, K.B., S. Gangappa, and S.H. Speck. 2006. Virgin HWt: Antibody-independent control of gamma-herpesvirus latency via B cell induction of anti-viral T cell responses. PLoS Pathogens 2: e58.PubMedCrossRef McClellan, K.B., S. Gangappa, and S.H. Speck. 2006. Virgin HWt: Antibody-independent control of gamma-herpesvirus latency via B cell induction of anti-viral T cell responses. PLoS Pathogens 2: e58.PubMedCrossRef
9.
go back to reference de Lima, B.D., J.S. May, S. Marques, J.P. Simas, and P.G. Stevenson. 2005. Murine gammaherpesvirus 68 bcl-2 homologue contributes to latency establishment in vivo. The Journal of General Virology 86: 31–40.PubMedCrossRef de Lima, B.D., J.S. May, S. Marques, J.P. Simas, and P.G. Stevenson. 2005. Murine gammaherpesvirus 68 bcl-2 homologue contributes to latency establishment in vivo. The Journal of General Virology 86: 31–40.PubMedCrossRef
10.
go back to reference Barton, E.S., D.W. White, J.S. Cathelyn, K.A. Brett-McClellan, M. Engle, M.S. Diamond, and V.L. Miller. 2007. Virgin HWt: Herpesvirus latency confers symbiotic protection from bacterial infection. Nature 447: 326–329.PubMedCrossRef Barton, E.S., D.W. White, J.S. Cathelyn, K.A. Brett-McClellan, M. Engle, M.S. Diamond, and V.L. Miller. 2007. Virgin HWt: Herpesvirus latency confers symbiotic protection from bacterial infection. Nature 447: 326–329.PubMedCrossRef
11.
go back to reference van Elden, L.J., M. Nijhuis, P. Schipper, R. Schuurman, and A.M. van Loon. 2001. Simultaneous detection of influenza viruses A and B using real-time quantitative PCR. Journal of Clinical Microbiology 39: 196–200.PubMedCrossRef van Elden, L.J., M. Nijhuis, P. Schipper, R. Schuurman, and A.M. van Loon. 2001. Simultaneous detection of influenza viruses A and B using real-time quantitative PCR. Journal of Clinical Microbiology 39: 196–200.PubMedCrossRef
12.
go back to reference Ito, T., M. Schaller, T. Raymond, A.D. Joshi, A.L. Coelho, F.G. Frantz, W.Ft. Carson, C.M. Hogaboam, N.W. Lukacs, T.J. Standiford, et al. 2009. Toll-like receptor 9 activation is a key mechanism for the maintenance of chronic lung inflammation. American Journal of Respiratory and Critical Care Medicine 180: 1227–1238. Ito, T., M. Schaller, T. Raymond, A.D. Joshi, A.L. Coelho, F.G. Frantz, W.Ft. Carson, C.M. Hogaboam, N.W. Lukacs, T.J. Standiford, et al. 2009. Toll-like receptor 9 activation is a key mechanism for the maintenance of chronic lung inflammation. American Journal of Respiratory and Critical Care Medicine 180: 1227–1238.
13.
go back to reference Lok, S.S., Y. Haider, D. Howell, J.P. Stewart, P.S. Hasleton, and J.J. Egan. 2002. Murine gammaherpes virus as a cofactor in the development of pulmonary fibrosis in bleomycin resistant mice. The European Respiratory Journal 20: 1228–1232.PubMedCrossRef Lok, S.S., Y. Haider, D. Howell, J.P. Stewart, P.S. Hasleton, and J.J. Egan. 2002. Murine gammaherpes virus as a cofactor in the development of pulmonary fibrosis in bleomycin resistant mice. The European Respiratory Journal 20: 1228–1232.PubMedCrossRef
14.
go back to reference Mora, A.L., C.R. Woods, A. Garcia, J. Xu, M. Rojas, S.H. Speck, J. Roman, K.L. Brigham, and A.A. Stecenko. 2005. Lung infection with gamma-herpesvirus induces progressive pulmonary fibrosis in Th2-biased mice. American Journal of Physiology. Lung Cellular and Molecular Physiology 289: L711–L721.PubMedCrossRef Mora, A.L., C.R. Woods, A. Garcia, J. Xu, M. Rojas, S.H. Speck, J. Roman, K.L. Brigham, and A.A. Stecenko. 2005. Lung infection with gamma-herpesvirus induces progressive pulmonary fibrosis in Th2-biased mice. American Journal of Physiology. Lung Cellular and Molecular Physiology 289: L711–L721.PubMedCrossRef
15.
go back to reference Yager, E.J., F.M. Szaba, L.W. Kummer, K.G. Lanzer, C.E. Burkum, and S.T. Smiley. 2009. Blackman MA: gamma-Herpesvirus-induced protection against bacterial infection is transient. Viral Immunology 22: 67–72.PubMedCrossRef Yager, E.J., F.M. Szaba, L.W. Kummer, K.G. Lanzer, C.E. Burkum, and S.T. Smiley. 2009. Blackman MA: gamma-Herpesvirus-induced protection against bacterial infection is transient. Viral Immunology 22: 67–72.PubMedCrossRef
16.
go back to reference Nguyen, Y., B.A. McGuffie, V.E. Anderson, and J.B. Weinberg. 2008. Gammaherpesvirus modulation of mouse adenovirus type 1 pathogenesis. Virology 380: 182–190.PubMedCrossRef Nguyen, Y., B.A. McGuffie, V.E. Anderson, and J.B. Weinberg. 2008. Gammaherpesvirus modulation of mouse adenovirus type 1 pathogenesis. Virology 380: 182–190.PubMedCrossRef
17.
go back to reference Haque, A., N. Rachinel, M.R. Quddus, S. Haque, L.H. Kasper, and E. Usherwood. 2004. Co-infection of malaria and gamma-herpesvirus: Exacerbated lung inflammation or cross-protection depends on the stage of viral infection. Clinical and Experimental Immunology 138: 396–404.PubMedCrossRef Haque, A., N. Rachinel, M.R. Quddus, S. Haque, L.H. Kasper, and E. Usherwood. 2004. Co-infection of malaria and gamma-herpesvirus: Exacerbated lung inflammation or cross-protection depends on the stage of viral infection. Clinical and Experimental Immunology 138: 396–404.PubMedCrossRef
18.
go back to reference Steed, A., T. Buch, and A. Waisman. 2007. Virgin HWt: Gamma interferon blocks gammaherpesvirus reactivation from latency in a cell type-specific manner. Journal of Virology 81: 6134–6140.PubMedCrossRef Steed, A., T. Buch, and A. Waisman. 2007. Virgin HWt: Gamma interferon blocks gammaherpesvirus reactivation from latency in a cell type-specific manner. Journal of Virology 81: 6134–6140.PubMedCrossRef
19.
go back to reference Elsawa, S.F., and K.L. Bost. 2004. Murine gamma-herpesvirus-68-induced IL-12 contributes to the control of latent viral burden, but also contributes to viral-mediated leukocytosis. Journal of Immunology 172: 516–524. Elsawa, S.F., and K.L. Bost. 2004. Murine gamma-herpesvirus-68-induced IL-12 contributes to the control of latent viral burden, but also contributes to viral-mediated leukocytosis. Journal of Immunology 172: 516–524.
20.
go back to reference Becker, S., J. Quay, and J. Soukup. 1991. Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages. Journal of Immunology 147: 4307–4312. Becker, S., J. Quay, and J. Soukup. 1991. Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages. Journal of Immunology 147: 4307–4312.
21.
go back to reference Ito, T., R.M. Allen, W.Ft. Carson, M. Schaller, K.A. Cavassani, C.M. Hogaboam, N.W. Lukacs, A. Matsukawa, and S.L. Kunkel. 2011. The critical role of Notch ligand Delta-like 1 in the pathogenesis of influenza A virus (H1N1) infection. PLoS Pathogens 7: e1002341. Ito, T., R.M. Allen, W.Ft. Carson, M. Schaller, K.A. Cavassani, C.M. Hogaboam, N.W. Lukacs, A. Matsukawa, and S.L. Kunkel. 2011. The critical role of Notch ligand Delta-like 1 in the pathogenesis of influenza A virus (H1N1) infection. PLoS Pathogens 7: e1002341.
22.
go back to reference Tumpey, T.M., A. Garcia-Sastre, J.K. Taubenberger, P. Palese, D.E. Swayne, M.J. Pantin-Jackwood, S. Schultz-Cherry, A. Solorzano, N. Van Rooijen, J.M. Katz, et al. 2005. Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: Functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. Journal of Virology 79: 14933–14944.PubMedCrossRef Tumpey, T.M., A. Garcia-Sastre, J.K. Taubenberger, P. Palese, D.E. Swayne, M.J. Pantin-Jackwood, S. Schultz-Cherry, A. Solorzano, N. Van Rooijen, J.M. Katz, et al. 2005. Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: Functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. Journal of Virology 79: 14933–14944.PubMedCrossRef
23.
go back to reference Kim, H.M., Y.W. Lee, K.J. Lee, H.S. Kim, S.W. Cho, N. van Rooijen, Y. Guan, and S.H. Seo. 2008. Alveolar macrophages are indispensable for controlling influenza viruses in lungs of pigs. Journal of Virology 82: 4265–4274.PubMedCrossRef Kim, H.M., Y.W. Lee, K.J. Lee, H.S. Kim, S.W. Cho, N. van Rooijen, Y. Guan, and S.H. Seo. 2008. Alveolar macrophages are indispensable for controlling influenza viruses in lungs of pigs. Journal of Virology 82: 4265–4274.PubMedCrossRef
24.
go back to reference White, D.W., C.R. Keppel, S.E. Schneider, T.A. Reese, J. Coder, J.E. Payton, T.J. Ley, H.W. Virgin, and T.A. Fehniger. 2010. Latent herpesvirus infection arms NK cells. Blood 115: 4377–4383.PubMedCrossRef White, D.W., C.R. Keppel, S.E. Schneider, T.A. Reese, J. Coder, J.E. Payton, T.J. Ley, H.W. Virgin, and T.A. Fehniger. 2010. Latent herpesvirus infection arms NK cells. Blood 115: 4377–4383.PubMedCrossRef
25.
go back to reference Xu, T., J. Qiao, L. Zhao, G. Wang, G. He, K. Li, Y. Tian, M. Gao, J. Wang, H. Wang, et al. 2006. Acute respiratory distress syndrome induced by avian influenza A (H5N1) virus in mice. American Journal of Respiratory and Critical Care Medicine 174: 1011–1017.PubMedCrossRef Xu, T., J. Qiao, L. Zhao, G. Wang, G. He, K. Li, Y. Tian, M. Gao, J. Wang, H. Wang, et al. 2006. Acute respiratory distress syndrome induced by avian influenza A (H5N1) virus in mice. American Journal of Respiratory and Critical Care Medicine 174: 1011–1017.PubMedCrossRef
26.
go back to reference Deng, G., J. Bi, F. Kong, X. Li, Q. Xu, J. Dong, M. Zhang, L. Zhao, Z. Luan, N. Lv, et al. 2010. Acute respiratory distress syndrome induced by H9N2 virus in mice. Archives of Virology 155: 187–195.PubMedCrossRef Deng, G., J. Bi, F. Kong, X. Li, Q. Xu, J. Dong, M. Zhang, L. Zhao, Z. Luan, N. Lv, et al. 2010. Acute respiratory distress syndrome induced by H9N2 virus in mice. Archives of Virology 155: 187–195.PubMedCrossRef
27.
go back to reference Fujisawa, H. 2008. Neutrophils play an essential role in cooperation with antibody in both protection against and recovery from pulmonary infection with influenza virus in mice. Journal of Virology 82: 2772–2783.PubMedCrossRef Fujisawa, H. 2008. Neutrophils play an essential role in cooperation with antibody in both protection against and recovery from pulmonary infection with influenza virus in mice. Journal of Virology 82: 2772–2783.PubMedCrossRef
28.
go back to reference Perrone, L.A., J.K. Plowden, A. Garcia-Sastre, J.M. Katz, and T.M. Tumpey. 2008. H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathogens 4: e1000115.PubMedCrossRef Perrone, L.A., J.K. Plowden, A. Garcia-Sastre, J.M. Katz, and T.M. Tumpey. 2008. H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathogens 4: e1000115.PubMedCrossRef
29.
go back to reference Chen, H.D., A.E. Fraire, I. Joris, R.M. Welsh, and L.K. Selin. 2003. Specific history of heterologous virus infections determines anti-viral immunity and immunopathology in the lung. The American Journal of Pathology 163: 1341–1355.PubMedCrossRef Chen, H.D., A.E. Fraire, I. Joris, R.M. Welsh, and L.K. Selin. 2003. Specific history of heterologous virus infections determines anti-viral immunity and immunopathology in the lung. The American Journal of Pathology 163: 1341–1355.PubMedCrossRef
Metadata
Title
MHV68 Latency Modulates the Host Immune Response to Influenza A Virus
Authors
Fumitake Saito
Toshihiro Ito
Judith M. Connett
Matthew A. Schaller
William F. Carson IV
Cory M. Hogaboam
Rosemary Rochford
Steven L. Kunkel
Publication date
01-12-2013
Publisher
Springer US
Published in
Inflammation / Issue 6/2013
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-013-9668-1

Other articles of this Issue 6/2013

Inflammation 6/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.